# Evaluation of Topical Application of BMX-010 in Subjects With Rosacea

> **NCT03756389** · PHASE2 · SUSPENDED · sponsor: **BioMimetix JV, LLC** · enrollment: 60 (estimated)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** BMX-010

## Key facts

- **NCT ID:** NCT03756389
- **Lead sponsor:** BioMimetix JV, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-01-03
- **Primary completion:** 2024-09
- **Final completion:** 2025-03
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** Re-formulation of study product
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03756389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03756389, "Evaluation of Topical Application of BMX-010 in Subjects With Rosacea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03756389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*